Quotient Sciences has been recognized in 10 CDMO Up & Comers 2026, GEN’s annual list highlighting contract development and manufacturing organizations making significant industry impact through growth, innovation, facility expansion, and strategic partnerships.
Advancing Pharmaceutical Innovation with an Award-Winning CDMO Partner
The recognition reflects Quotient Sciences’ continued commitment to accelerating drug development through integrated services, scientific expertise, and innovative technologies that help sponsors bring medicines to patients faster.
Read the full article on Geneng News website here.